type 1 diabetes

MannKind Completes Phase 3 Clinical Study of AFREZZA in Patients with Type 1 Diabetes

MannKind Completes Phase 3 Clinical Study of AFREZZA in Patients with Type 1 Diabetes

Yahoo

Johnson & Johnson, Medtronic Frontrunners In Race To Develop Artificial Pancreas

Johnson & Johnson, Medtronic Frontrunners In Race To Develop Artificial Pancreas

Seeking Alpha

Oramed Pharmaceuticals Moves Forward with Investigational New Drug Application for Oral Insulin

Oramed Pharmaceuticals Moves Forward with Investigational New Drug Application for Oral Insulin

PharmaLive

Long MannKind's Afrezza: Shares Versus A Bull Call Spread

Long MannKind's Afrezza: Shares Versus A Bull Call Spread

Seeking Alpha

3 Reasons This Speculative Bio-Pharma Is A Winner

3 Reasons This Speculative Bio-Pharma Is A Winner

Seeking Alpha

Diabetes May Be Reversed By Long-Used Vaccine For TB

Diabetes May Be Reversed By Long-Used Vaccine For TB

Bloomberg

Novo Nordisk, JDRF collaborating on R&D for type 1 diabetes

Novo Nordisk, JDRF collaborating on R&D for type 1 diabetes

Yahoo/Fly on the Wall

Symlin Use Helped Patients with Type 2 or Type 1 Diabetes Achieve More Time in Normal Glucose Range

Symlin Use Helped Patients with Type 2 or Type 1 Diabetes Achieve More Time in Normal Glucose Range

Yahoo/Business Wire

Novo Nordisk Establishes Type 1 Diabetes R&D Center in Seattle

Novo Nordisk Establishes Type 1 Diabetes R&D Center in Seattle

Yahoo

Osiris' Update on Prochymal

Osiris' Update on Prochymal

Yahoo/Zacks